(4-BROMO-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE
|
- $200 - $874
- Product name: (4-BROMO-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE
- CAS: 510723-60-1
- MF: C13H13BrN2
- MW: 277.16
- EINECS:
- MDL Number:MFCD03724418
- Synonyms:(4-BROMO-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE;1-(4-BROMOPHENYL)-N-(PYRIDIN-3-YLMETHYL)METHANAMINE;N-(4-BROMOBENZYL)-N-(PYRIDIN-3-YLMETHYL)AMINE;3-Pyridinemethanamine, N-[(4-bromophenyl)methyl]-;N-[(4-Bromophenyl)methyl]-3-pyridinemethanamine
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0038028
- Product description(4-BROMO-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE 95.00%
- Packaging500MG
- Price$768.08
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11113633
- Product descriptionN-(4-Bromobenzyl)-1-(pyridin-3-yl)methanamine 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010650
- Product description(4-Bromo-benzyl)-pyridin-3-ylmethyl-amine
- Packaging500mg
- Price$200
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number010650
- Product description(4-Bromo-benzyl)-pyridin-3-ylmethyl-amine
- Packaging1g
- Price$308
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0038028 | (4-BROMO-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE 95.00% | 500MG | $768.08 | 2021-12-16 | Buy |
| Crysdot | CD11113633 | N-(4-Bromobenzyl)-1-(pyridin-3-yl)methanamine 97% | 5g | $874 | 2021-12-16 | Buy |
| Matrix Scientific | 010650 | (4-Bromo-benzyl)-pyridin-3-ylmethyl-amine | 500mg | $200 | 2021-12-16 | Buy |
| Matrix Scientific | 010650 | (4-Bromo-benzyl)-pyridin-3-ylmethyl-amine | 1g | $308 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|